
Xp11.2 translocation renal cell carcinoma (RCC) is a newly identified category of RCC described in the 2004 WHO Classification of Kidney Tumors. Although the incidence is very rare, it accounts about one third of pediatric RCCs. It is different from other RCCs in clinical manifestations, histopathologic features, biological behaviour and prognosis. At present, Xp11.2 translocation RCC has seldom been reported. This review analyzed recent researches on Xp11.2 translocation RCC, described its classification and summarized the characteristics of epidemiology, clinical manifestations, histopathology, diagnosis, treatment and prognosis.
Chromosomes, Human, X, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Lymphatic Metastasis, Humans, Prognosis, Carcinoma, Renal Cell, Kidney Neoplasms, Translocation, Genetic
Chromosomes, Human, X, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Lymphatic Metastasis, Humans, Prognosis, Carcinoma, Renal Cell, Kidney Neoplasms, Translocation, Genetic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
